FDA Clearance Tracker · P980043-S002
HANCOCK II PORCINE BIOPROSTHESIS MODEL T505 (AORTIC)
Last checked: Nov 20, 2026Latest source record: Oct 28, 2002 (this decision)Source: openFDAMethods & limitations
Decided
Oct 28, 2002
Approved
Time to decision
180 days
Received May 1, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P980043-S002
- Device name
- HANCOCK II PORCINE BIOPROSTHESIS MODEL T505 (AORTIC)
- Applicant
- Medtronic, Inc.
- Applicant location
- Santa Ana, CA
- Received
- May 1, 2002
- Decided
- Oct 28, 2002
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P980043
Device type
- Device type
- replacement Heart-valve (DYE)
- Device class
- Class III
- Regulation
- 21 CFR 870.3925
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR MODIFICATIONS TO THE VALVE HOLDERS FOR THE HANCOCK II BIOPROSTHESIS. THE HOLDERS ARE TO BE USED WITH THE FOLLOWING APPROVED VALVE MODELS AND SIZES: HANCOCK II PORCINE BIOPROSTHESIS, MODEL T505 (AORTIC, SIZES 21, 23, 25, 27, AND 29 MM. THESE AORTIC VALVES ARE INDICATED FOR THE REPLACEMENT OF MALFUNCTIONING NATIVE OR PROSTHETIC AORTIC VALVES.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.